Key Insights

Highlights

Success Rate

69% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

17.4%

4 terminated out of 23 trials

Success Rate

69.2%

-17.3% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

3 of 9 completed with results

Key Signals

3 with results69% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (3)
Early P 1 (2)
P 1 (1)
P 2 (1)

Trial Status

Completed9
Recruiting5
Terminated4
Unknown3
Not Yet Recruiting2

Trial Success Rate

69.2%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT05051722Recruiting

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

NCT04051502Early Phase 1Completed

ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study

NCT05017246Phase 2Terminated

Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy

NCT03297112Early Phase 1CompletedPrimary

Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery

NCT06828419Not ApplicableNot Yet Recruiting

A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery

NCT05761275Not ApplicableRecruiting

Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach

NCT06693596RecruitingPrimary

Masses in Young Patients - International Ovarian Tumour Analysis (MY-IOTA)

NCT06528236Not Yet Recruiting

Research and Application of Ultrasonic Intelligent Diagnosis System for Ovarian Mass

NCT05842629Recruiting

Improved Diagnosis of Ovarian Cancer

NCT03837327CompletedPrimary

Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy

NCT06366997Completed

Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test

NCT04487405TerminatedPrimary

A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants

NCT04668521TerminatedPrimary

Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection

NCT05974618RecruitingPrimary

Prospective Validation of the ADNEX Model for Discrimination Between Benign and Malignant Adnexal Masses in Pregnancy: International Ovarian Tumour Analysis in Pregnancy Study (p-IOTA)

NCT05815992UnknownPrimary

Accuracy of the Characterization of Adnexal Masses, Indeterminate at Ultrasonography, Using a MRI Protocol Without Contrast: Validation of the Cambridge Score

NCT05461872UnknownPrimary

Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES

NCT04260334Not ApplicableCompletedPrimary

Preoperative Care In Ovarian Cancer Patients

NCT03593681Completed

Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy

NCT03485651TerminatedPrimary

Natera Ovarian Cancer Detection Assay

NCT02520115Phase 1CompletedPrimary

Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer

Scroll to load more

Research Network

Activity Timeline